This website uses cookies to enhance the user experience.
21st logo
||
F

FERRING LEGEMIDLER AS975 859 932

Purchase and sale
Limited company
Nydalsveien 28 0484 OSLO, Norge

FERRING LEGEMIDLER AS

Operating
Agentvirksomhet, salg og markedsføring av legemidler, samt annen virksomhet som naturlig hører til.

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Organization

CEO
ML

Maja Lassenius Kramp1980

Chairman of the board
MA

Mario Alejandro Esteves Durand1966

Years since formation
31 years
since Nov 7, 1995
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
100
1 share class
Total number of shareholders
1
person

Financials

Total operating income 2025
107,329,955
NOK
Annual total result 2025
2,564,224
NOK
Total equity 2025
8,312,566
NOK
Last update: Oct 7, 2026

Management

Management / administration

NameRoleShares
ML

Maja Lassenius Kramp

1980

Managing Director/CEO-

Board

NameRoleShares
MA

Mario Alejandro Esteves Durand

1966

Chairman-
EM

Eric Michel Breumier

1964

Board Member-

Others

NameRoleShares
D
DELOITTE AS
Auditor-
E
ECONPARTNER AS
Accountant-
A
AZETS INSIGHT AS
Accountant-
C
CEDRA NORGE AS
Accountant-
Last update: Oct 7, 2026

Ownership

Company shareholders

NameShare classTotal number of sharesShare
BF

Bv Ferring

Ordinary shares
100
100 %
Last update: Sep 25, 2026

Financials

in NOK

Summary

Year20252024202320222021
Total operating income
107,329,955
162,090,776
152,158,341
154,706,090
165,088,696
Annual Total Result
2,564,224
3,434,550
3,009,458
3,828,474
3,275,560
Total assets
53,172,906
74,129,112
78,878,834
68,440,362
82,349,521
Total liabilities
44,860,340
63,205,164
60,543,569
53,108,508
71,502,721
Total equity
8,312,566
10,923,948
18,335,265
15,331,854
10,846,800

P&L

Year20252024202320222021
Total operating income
107,329,955
162,090,776
152,158,341
154,706,090
165,088,696
Total operating costs
103,662,276
157,066,082
146,480,325
149,375,091
160,674,325
Operating result
3,667,679
5,024,694
5,678,016
5,330,999
4,414,371
Financial income/costs
-279,994
-479,949
-1,547,127
-20,797
49,426
Profit before tax
3,387,685
4,544,745
4,130,889
5,310,202
4,463,797
Total tax & extraordinary income/cost
823,461
1,110,195
1,121,431
1,481,728
1,188,237
Annual Total Result
2,564,224
3,434,550
3,009,458
3,828,474
3,275,560

Balance overview

Year20252024202320222021
Total fixed assets
1,778,187
837,065
1,193,897
851,739
800,912
Total current assets
51,394,719
73,292,047
77,684,937
67,588,623
81,548,609
Total assets
53,172,906
74,129,112
78,878,834
68,440,362
82,349,521
Short term debt
44,860,340
63,205,164
60,543,569
53,108,508
71,121,220
Long term debt
0
0
0
0
381,501
Total liabilities
44,860,340
63,205,164
60,543,569
53,108,508
71,502,721
Contributed capital
500,000
500,000
500,000
500,000
500,000
Retained earnings
7,812,566
10,423,948
17,835,265
14,831,854
10,346,800
Total equity
8,312,566
10,923,948
18,335,265
15,331,854
10,846,800
Total equity and liabilities
53,172,906
74,129,112
78,878,834
68,440,362
82,349,521

Classification

21st company classification
BETA
Industrial large enterprise
Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
G
Main industrial area
Wholesale and retail trade; repair of motor vehicles and motorcycles
46
Activity
Wholesale trade, except of motor vehicles and motorcycles
46.4
Main industrial group
Wholesale of household goods
46.46
Industrial group
Wholesale of pharmaceutical goods
46.460
Industrial group
Wholesale of pharmaceutical goods